Diphenylhydantoin protection of centpiperalone induced insulin release from beta-cells.
D000818:Animals; D001786:Blood Glucose; D003594:Cytoplasmic Granules / Q000187:drug effects; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D008297:Male; D010672:Phenytoin / Q000494:pharmacology*; D010879:Piperazines; D010880:Piperidines / Q000494:pharmacology*; D011799:Quinazolines / Q000494:pharmacology*; D052999:Quinazolinones; D051381:Rats
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D010879:Piperazines; D010880:Piperidines; D011799:Quinazolines; D052999:Quinazolinones; C008918:centpiperalone; D010672:Phenytoin